Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Times Interest Earned (2016 - 2024)

Historic Times Interest Earned for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 16 years, with Q4 2024 value amounting to -$0.42.

  • Lifecore Biomedical, Inc. \De\'s Times Interest Earned rose 739.2% to -$0.42 in Q4 2024 from the same period last year, while for May 2025 it was -$1.91, marking a year-over-year decrease of 21688.8%. This contributed to the annual value of -$0.6 for FY2024, which is 5231.97% up from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Times Interest Earned stood at -$0.42 for Q4 2024, which was up 739.2% from -$2.63 recorded in Q3 2024.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Times Interest Earned registered a high of $1.33 during Q4 2021, and its lowest value of -$6.79 during Q1 2020.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median Times Interest Earned value was -$0.85 (recorded in 2021), while the average stood at -$1.33.
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Times Interest Earned tumbled by 930169.18% in 2022, and later surged by 13665.52% in 2024.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Times Interest Earned (Quarter) stood at $0.86 in 2020, then soared by 54.9% to $1.33 in 2021, then plummeted by 211.23% to -$1.48 in 2022, then skyrocketed by 69.15% to -$0.46 in 2023, then grew by 7.39% to -$0.42 in 2024.
  • Its last three reported values are -$0.42 in Q4 2024, -$2.63 for Q3 2024, and $0.44 during Q2 2024.